Steven Brugger

Steven Brugger is the Chief Executive Officer of BrainChild Bio since December 2023. Prior to that, Steven held various leadership positions at companies such as Strategic Science and Technologies, LLC, GSK, Affinivax Inc., Visterra, Inc, Momenta Pharmaceuticals, Millennium Pharmaceuticals, Novartis Pharmaceuticals, and Ayerst Pharmaceuticals. Steven holds an MBA in Business from Rutgers University - Newark and a BA in Biology and Chemistry from Susquehanna University.